Sam Ohlinger, JD, Author at Archbow Consulting - Pharmaceutical & Biotech Consultants in USA and Europe

Tracking

CMS BFSF Rule: Critical Changes Every Pharma Company Must Address

by Sam Ohlinger, JD | Feb 10 | Industry News, Strategy

INSIGHTS Home 9 Author archive for Sam Ohlinger, JD Sam Ohlinger, JD • CMS BFSF Rule: Critical Changes Every Pharma Company Must Address Manufacturers must now submit ASP data with FMV documentation and BFSF fee certification for Medicare...

Understanding Fair Market Value

by Sam Ohlinger, JD | Mar 27 | HUBs, Market Access, Strategy

INSIGHTS Home 9 Tag: Pharma • Understanding Fair Market Value Why Fair Market Value Matters and How Archbow Consulting Can Help You Navigate It Understanding Fair Market Value: Why It Matters and How Archbow Consulting Can Help You...